Research indicates that the BTOGP‐GPC3 molecule has exceptional overall characteristics in diagnosing and treating advanced tumors, serving as a potent molecular instrument for accurately diagnosing and managing HCC. The gene discussed is GPC3; the disease is hepatocellular carcinoma.